The Trogarzo® loading dose can also be administered as an undiluted intravenous (IV) push over 90 seconds, and the maintenance dose can be administered as an undiluted IV push over 30 seconds ...

(RTTNews) - Theratechnologies Inc. (THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received FDA approval for the intravenous push ...

An intravenous (IV) injection is a fast and accurate way of administering a medication. ... Push a small plastic catheter over the needle and into the vein. Remove the needle, ...

The Food and Drug Administration (FDA) has approved Trogarzo ® (ibalizumab-uiyk) for administration by intravenous (IV) push for maintenance dosing.. Trogarzo is a CD4-directed post-attachment ...

Safety profile of Trogarzo® IV push similar to that of IV infusion New method of administration designed to make maintenance dosing easier for patients and health care providers and allow ...

The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated to include a 90-second intravenous (IV) push loading dose.. Trogarzo, a CD4-directed post-attachment HIV-1 inhibitor ...

Theratechnologies. Reduces maintenance dose from a 15-minute IV infusion to a 30-second, undiluted IV push every two weeks. Safety profile of Trogarzo ® IV push similar to that of IV infusion ...

(RTTNews) - Theratechnologies Inc. (THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received FDA approval for the intravenous push ...

Factor VIII replacement therapy needs frequent intravenous injections. For half-life products this varies and could range from every 2 days to every 4 days, which can be self-administered through slow ...

Release Summary. Vizient has published a conservation guide for adult and pediatric IV push medications to help mitigate potential hurricane-caused supply disruptions.